NeoGenomics Reports Fourth Quarter and Full Year 2023 Result

NeoGenomics, Inc. (the "Company"), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023.


Highlights



Fourth quarter...

Related Keywords

Fort Myers , Florida , United States , Cambridge , Cambridgeshire , United Kingdom , San Diego , California , Houston , Texas , Aliso Viejo , North Carolina , Research Triangle Park , Chris Smith , Company Advanced Diagnostics Division , Nasdaq , Neogenomics Inc , Clinical Services , Company Annual Report On Form , Exchange Commission , Conference Call , Genomics Reports Fourth Quarter , Full Year , Advanced Diagnostics , Adjusted Gross Profit , Adjusted Net , Adjusted Gross Profit Margin , Adjusted Net Loss , Adjusted Diluted , Investor Relations , Advanced Diagnostics Division , Privacy Practices , Annual Report , Quarterly Reports , Ended December , Gross Profit , Gross Profit Margin , Months Ended December , Net Loss , Tests Performed ,